T1	Outcomes 264 354	changes in transcutaneous PCO2 (tcPCO2), subjective anxiety, heart rate and blood pressure
T2	Outcomes 524 570	fall in tcPCO2 and the cardiovascular response
T3	Outcomes 752 775	acute hyperventilation,
T4	Outcomes 902 948	occurrence of anxiety-related somatic symptoms